Issues important to the design of stroke recovery trials
Lancet Neurol
.
2020 Mar;19(3):197-198.
doi: 10.1016/S1474-4422(20)30030-2.
Author
Steven C Cramer
1
Affiliation
1
Department of Neurology, University of California, Los Angeles, CA 90095-1769, USA; California Rehabilitation Institute; Los Angeles, CA, USA. Electronic address: sccramer@mednet.ucla.edu.
PMID:
32085829
DOI:
10.1016/S1474-4422(20)30030-2
No abstract available
Publication types
Comment
MeSH terms
Benzodiazepines
Brain Ischemia*
Double-Blind Method
Humans
Oxazoles
Stroke Rehabilitation*
Stroke*
Substances
Oxazoles
S44819
Benzodiazepines